Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Adenosine A3 Receptor Protein (ADORA3) (His tag)

ADORA3 Origin: Rat Host: Escherichia coli (E. coli) Recombinant > 97 % WB, SDS, Imm, PC
Catalog No. ABIN7415800
  • Target See all Adenosine A3 Receptor (ADORA3) Proteins
    Adenosine A3 Receptor (ADORA3)
    Protein Type
    Recombinant
    Origin
    • 4
    • 1
    Rat
    Source
    • 2
    • 2
    • 1
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This Adenosine A3 Receptor protein is labelled with His tag.
    Application
    Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
    Characteristics
    Recombinant Adenosine A3 Receptor (ADORA3), Prokaryotic expression, , N-terminal His Tag
    Purity
    > 97 %
    Top Product
    Discover our top product ADORA3 Protein
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Isoelectric Point:

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-80 °C
    Storage Comment
    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
    Expiry Date
    12 months
  • Target
    Adenosine A3 Receptor (ADORA3)
    Alternative Name
    Adenosine A3 Receptor (ADORA3 Products)
    Synonyms
    A3AR Protein, AD026 Protein, bA552M11.5 Protein, ADORA3 Protein, 1700001D09Rik Protein, 4930578J19Rik Protein, A3R Protein, AA3R Protein, ARA3 Protein, Gpcr2 Protein, adenosine A3 receptor Protein, adenosine receptor A3 Protein, ADORA3 Protein, Adora3 Protein, LOC100603318 Protein
    Background
    A3AR, AD026
    Pathways
    Hormone Transport, cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here: